WDC
41
-2
GIS
26
3
IFF
53
2
AMP
69
-3
T
50
3
PBI
60
-5
HUM
48
6
BIIB
26
2
USB
50
2
EOG
58
2
AIG
38
-4
IP
70
2
TEL
60
2
AXP
66
2
CSCO
63
2
MKC
56
8
EXC
54
-2
MPC
47
3
OXY
40
3
UNH
61
6
WDC
41
-2
GIS
26
3
IFF
53
2
AMP
69
-3
T
50
3
PBI
60
-5
HUM
48
6
BIIB
26
2
USB
50
2
EOG
58
2
AIG
38
-4
IP
70
2
TEL
60
2
AXP
66
2
CSCO
63
2
MKC
56
8
EXC
54
-2
MPC
47
3
OXY
40
3
UNH
61
6
Financhill
Back

Matinas BioPharma Holdings Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.58
Seasonality Move:
5.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Matinas BioPharma Holdings Stock Forecast

  • Is Matinas BioPharma Holdings Stock Undervalued?
    The current Matinas BioPharma Holdings [MTNB] share price is $0.54. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Matinas BioPharma Holdings Stock Go Up Next Year?

Data Unavailable

Matinas BioPharma Holdings Stock Rating

Data Unavailable

Matinas BioPharma Holdings Stock Price History

Is MTNB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
matinasbiopharma.com

52-Week Data

52-Week High:
21.50
52-Week Low:
0.50

Prediction Charts

Market Cap:
2.75M
Price in USD:
0.54
Volume:
65.99K
Beta:
1.74

Technical Analysis

SMA50:
2.57
SMA100:
1.57
SMA200:
0.89
52-Wk Change:
-95.38%

Stock Predictions

  • Is Matinas BioPharma Holdings stock public?
    Yes, Matinas BioPharma Holdings is a publicly traded company.
  • What is the Matinas BioPharma Holdings stock quote today?
    The Matinas BioPharma Holdings stock price is 0.54 USD today.
  • How to buy Matinas BioPharma Holdings stock online?
    You can buy Matinas BioPharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 0.61 0.58 0.61 0.55
Nov-4 0.56 0.57 0.58 0.51
Nov-5 0.56 0.55 0.57 0.52
Nov-6 0.54 0.53 0.56 0.50
Nov-7 0.52 0.56 0.57 0.50
Nov-8 0.61 0.70 0.76 0.60
Nov-11 0.69 0.90 1.08 0.69
Nov-12 0.84 0.75 0.97 0.69
Nov-13 0.75 0.71 0.76 0.62
Nov-14 0.67 0.63 0.79 0.50
Nov-15 0.63 0.62 0.63 0.59
Nov-18 0.62 0.61 0.65 0.55
Nov-19 0.58 0.57 0.60 0.56
Nov-20 0.55 0.54 0.58 0.54

Matinas BioPharma Holdings Earnings

Data Unavailable

Matinas BioPharma Holdings Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.

* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.